PATHOBIOLOGY OF ATHEROSCLEROSIS AND PLAQUE COMPLICATIONS

被引:42
作者
DZAU, VJ
机构
[1] Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University School of Medicine Stanford, CA
关键词
D O I
10.1016/0002-8703(94)90251-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To understand the process of atherosclerosis, the homeostatic and protective functions of the endothelium must be considered. The endothelium serves as the interface between blood flow and the vascular tissues. It normally regulates vascular tone and structure through the release of vasoactive substances and maintenance of a nonthrombogenic surface. Endothelial dysfunction, which results from biochemical and hemodynamic stresses associated with cardiovascular risk factors, causes an imbalance in the expression of vasodilating and vasoconstricting substances, as well as excess production of chemoattractant molecules and growth factors. Endothelial dysfunction in the presence of elevated cholesterol levels fosters the development of fatty streaks, which represent the early stage of atherosclerotic plaque. The unstable progression of atherosclerosis can be interrupted and even reversed in both animals and humans, although the exact clinical correlates of progression and regression are not fully understood.
引用
收藏
页码:1300 / 1304
页数:5
相关论文
共 36 条
[1]   LIPID-LOWERING AND PLAQUE REGRESSION - NEW INSIGHTS INTO PREVENTION OF PLAQUE DISRUPTION AND CLINICAL EVENTS IN CORONARY-DISEASE [J].
BROWN, BG ;
ZHAO, XQ ;
SACCO, DE ;
ALBERS, JJ .
CIRCULATION, 1993, 87 (06) :1781-1791
[2]   REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].
BROWN, G ;
ALBERS, JJ ;
FISHER, LD ;
SCHAEFER, SM ;
LIN, JT ;
KAPLAN, C ;
ZHAO, XQ ;
BISSON, BD ;
FITZPATRICK, VF ;
DODGE, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298
[3]   LEUKOCYTE-ENDOTHELIAL CELL RECOGNITION - 3 (OR MORE) STEPS TO SPECIFICITY AND DIVERSITY [J].
BUTCHER, EC .
CELL, 1991, 67 (06) :1033-1036
[4]   ANTIATHEROGENIC EFFECTS OF L-ARGININE IN THE HYPERCHOLESTEROLEMIC RABBIT [J].
COOKE, JP ;
SINGER, AH ;
TSAO, P ;
ZERA, P ;
ROWAN, RA ;
BILLINGHAM, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :1168-1172
[5]   L-ARGININE IMPROVES ENDOTHELIUM-DEPENDENT VASODILATION IN HYPERCHOLESTEROLEMIC HUMANS [J].
CREAGER, MA ;
GALLAGHER, SJ ;
GIRERD, XJ ;
COLEMAN, SM ;
DZAU, VJ ;
COOKE, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1248-1253
[6]   IMPAIRED VASODILATION OF FOREARM RESISTANCE VESSELS IN HYPERCHOLESTEROLEMIC HUMANS [J].
CREAGER, MA ;
COOKE, JP ;
MENDELSOHN, ME ;
GALLAGHER, SJ ;
COLEMAN, SM ;
LOSCALZO, J ;
DZAU, VJ .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) :228-234
[7]   ENDOTHELIAL EXPRESSION OF A MONONUCLEAR LEUKOCYTE ADHESION MOLECULE DURING ATHEROGENESIS [J].
CYBULSKY, MI ;
GIMBRONE, MA .
SCIENCE, 1991, 251 (4995) :788-791
[8]  
DAVIES MJ, 1985, BRIT HEART J, V53, P363
[9]   CORRECTION OF ENDOTHELIAL DYSFUNCTION IN CORONARY MICROCIRCULATION OF HYPERCHOLESTEROLEMIC PATIENTS BY L-ARGININE [J].
DREXLER, H ;
ZEIHER, AM ;
MEINZER, K ;
JUST, H .
LANCET, 1991, 338 (8782-3) :1546-1550